Matches in SemOpenAlex for { <https://semopenalex.org/work/W2558511210> ?p ?o ?g. }
- W2558511210 endingPage "74" @default.
- W2558511210 startingPage "74" @default.
- W2558511210 abstract "As part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T) we report the in vitro activity of tigecycline and its comparators against Gram-negative and Gram-positive organisms collected from Italian centers between 2012 and 2014. Minimum inhibitory concentrations were determined according to the broth microdilution methodology of the Clinical and Laboratory Standards Institute, and antimicrobial resistance was determined using the European Committee on Antimicrobial Susceptibility Testing interpretive criteria. Among the Enterobacteriaceae, 31% of Escherichia coli isolates, 22% of Klebsiella pneumoniae, and 1% of Klebsiella oxytoca were extended-spectrum β-lactamase producers (ESBLs). Resistance rates among ESBL-K. pneumoniae and ESBL-E. coli to meropenem were 24% and <1%, respectively. Thirty-seven percent of K. pneumoniae were multidrug resistant (MDR) strains. Resistance rates among isolates of Acinetobacter baumannii to amikacin, levofloxacin and meropenem were between 84% and 94%. Eighty percent of A. baumannii isolates were MDR strains. Methicillin-resistant Staphylococcus aureus (MRSA) accounted for 38% of S. aureus isolates. No isolates of MRSA were resistant to linezolid, tigecycline or vancomycin. Antimicrobial resistance remains a problem in Italy with increasing numbers of MDR organisms. Despite high levels, MRSA rates appear to be stabilising. Tigecycline retains its in vitro activity against the majority of organisms, including those with multidrug resistance." @default.
- W2558511210 created "2016-12-08" @default.
- W2558511210 creator A5037042809 @default.
- W2558511210 creator A5082800922 @default.
- W2558511210 date "2016-11-26" @default.
- W2558511210 modified "2023-09-27" @default.
- W2558511210 title "Assessment of the Activity of Tigecycline against Gram-Positive and Gram-Negative Organisms Collected from Italy between 2012 and 2014, as Part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)" @default.
- W2558511210 cites W1440840831 @default.
- W2558511210 cites W1526988668 @default.
- W2558511210 cites W1869453106 @default.
- W2558511210 cites W1931850854 @default.
- W2558511210 cites W1989491916 @default.
- W2558511210 cites W2007333547 @default.
- W2558511210 cites W2016132030 @default.
- W2558511210 cites W2023644818 @default.
- W2558511210 cites W2051248332 @default.
- W2558511210 cites W2056829631 @default.
- W2558511210 cites W2070722941 @default.
- W2558511210 cites W2085878915 @default.
- W2558511210 cites W2096172395 @default.
- W2558511210 cites W2099246144 @default.
- W2558511210 cites W2103623737 @default.
- W2558511210 cites W2111920827 @default.
- W2558511210 cites W2118897654 @default.
- W2558511210 cites W2141646069 @default.
- W2558511210 cites W2142343447 @default.
- W2558511210 cites W2142696006 @default.
- W2558511210 cites W2142827309 @default.
- W2558511210 cites W2152944378 @default.
- W2558511210 cites W2158629630 @default.
- W2558511210 cites W2159435953 @default.
- W2558511210 cites W2159560564 @default.
- W2558511210 cites W2162401848 @default.
- W2558511210 cites W2326175595 @default.
- W2558511210 cites W2400586161 @default.
- W2558511210 cites W2494086912 @default.
- W2558511210 doi "https://doi.org/10.3390/ph9040074" @default.
- W2558511210 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5198049" @default.
- W2558511210 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27898030" @default.
- W2558511210 hasPublicationYear "2016" @default.
- W2558511210 type Work @default.
- W2558511210 sameAs 2558511210 @default.
- W2558511210 citedByCount "5" @default.
- W2558511210 countsByYear W25585112102017 @default.
- W2558511210 countsByYear W25585112102018 @default.
- W2558511210 countsByYear W25585112102019 @default.
- W2558511210 countsByYear W25585112102023 @default.
- W2558511210 crossrefType "journal-article" @default.
- W2558511210 hasAuthorship W2558511210A5037042809 @default.
- W2558511210 hasAuthorship W2558511210A5082800922 @default.
- W2558511210 hasBestOaLocation W25585112101 @default.
- W2558511210 hasConcept C104317684 @default.
- W2558511210 hasConcept C114851261 @default.
- W2558511210 hasConcept C133936738 @default.
- W2558511210 hasConcept C176947019 @default.
- W2558511210 hasConcept C2776315533 @default.
- W2558511210 hasConcept C2777027569 @default.
- W2558511210 hasConcept C2777058267 @default.
- W2558511210 hasConcept C2777637488 @default.
- W2558511210 hasConcept C2778050735 @default.
- W2558511210 hasConcept C2778980435 @default.
- W2558511210 hasConcept C2779375183 @default.
- W2558511210 hasConcept C2779489039 @default.
- W2558511210 hasConcept C2780950330 @default.
- W2558511210 hasConcept C2781414143 @default.
- W2558511210 hasConcept C4937899 @default.
- W2558511210 hasConcept C501593827 @default.
- W2558511210 hasConcept C523546767 @default.
- W2558511210 hasConcept C54355233 @default.
- W2558511210 hasConcept C547475151 @default.
- W2558511210 hasConcept C55493867 @default.
- W2558511210 hasConcept C71924100 @default.
- W2558511210 hasConcept C86803240 @default.
- W2558511210 hasConcept C89423630 @default.
- W2558511210 hasConcept C94665300 @default.
- W2558511210 hasConceptScore W2558511210C104317684 @default.
- W2558511210 hasConceptScore W2558511210C114851261 @default.
- W2558511210 hasConceptScore W2558511210C133936738 @default.
- W2558511210 hasConceptScore W2558511210C176947019 @default.
- W2558511210 hasConceptScore W2558511210C2776315533 @default.
- W2558511210 hasConceptScore W2558511210C2777027569 @default.
- W2558511210 hasConceptScore W2558511210C2777058267 @default.
- W2558511210 hasConceptScore W2558511210C2777637488 @default.
- W2558511210 hasConceptScore W2558511210C2778050735 @default.
- W2558511210 hasConceptScore W2558511210C2778980435 @default.
- W2558511210 hasConceptScore W2558511210C2779375183 @default.
- W2558511210 hasConceptScore W2558511210C2779489039 @default.
- W2558511210 hasConceptScore W2558511210C2780950330 @default.
- W2558511210 hasConceptScore W2558511210C2781414143 @default.
- W2558511210 hasConceptScore W2558511210C4937899 @default.
- W2558511210 hasConceptScore W2558511210C501593827 @default.
- W2558511210 hasConceptScore W2558511210C523546767 @default.
- W2558511210 hasConceptScore W2558511210C54355233 @default.
- W2558511210 hasConceptScore W2558511210C547475151 @default.
- W2558511210 hasConceptScore W2558511210C55493867 @default.
- W2558511210 hasConceptScore W2558511210C71924100 @default.
- W2558511210 hasConceptScore W2558511210C86803240 @default.
- W2558511210 hasConceptScore W2558511210C89423630 @default.